Viewing Study NCT05303532

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2026-01-04 @ 12:12 AM
Study NCT ID: NCT05303532
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-11-26
First Post: 2022-02-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None Oncology View
None Clinically Benefit View
None Roll Over StudY View
None Durvalumab View